Spots Global Cancer Trial Database for Fibroid Ablation Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Fibroid Ablation Study
Official Title: Symptom Effectiveness Study of VizAblate™ Intrauterine Ultrasound-Guided RF Ablation (IUUSgRFA) in the Ablation of Uterine Fibroids
Study ID: NCT01226290
Interventions
Study Description
Brief Summary: The primary objective of this study is to establish the effectiveness and confirm the safety of the VizAblate System in ablating symptomatic uterine fibroids.
Detailed Description:
Eligibility
Minimum Age: 28 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Universidad Autonoma de Nuevo Leon (UANL), Monterrey, Nuevo Leon, Mexico
Máxima Medisch Centrum, Veldhoven, Noord-Brabant, Netherlands
Vrije Universiteit Medisch Centrum, Amsterdam, North Holland, Netherlands
St. Antonius Ziekenhuis, Nieuwegein, Utrecht, Netherlands
Medisch Spectrum Twente, Enschede, , Netherlands
Royal London Hospital, Whitechapel, London, United Kingdom
Birmingham Women's NHS Foundation Trust, Birmingham, West Midlands, United Kingdom
Princess Royal Hospital, Haywards Health, West Sussex, United Kingdom
Bradford Teaching Hospitals NHS Trust, Bradford, West Yorkshire, United Kingdom
University College Hospital, London, , United Kingdom
Contact Details
Name: David Toub, MD
Affiliation: Gynesonics
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
